Delivery Order SPE2DB20D3103-SPE2DB22FN6X2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,248.06 firm fixed-price delivery order is for the supply of LEVEMIR 100 UNIT/ML VIAL 10ML, a prescription medication. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Levemir 100 unit/mL vials. The $7,462.58 firm fixed-price delivery order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as a primary mechanism for Amerisourcebergen to supply a...
- This federal contract award to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $1,001.64 to provide Levemir 100 unit/ml vial 10ml to the Department of Defense's Medical Supply Chain (also known as DLA Troop Support Medical). The contract has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,608.41 firm fixed-price delivery order is for the supply of LEVEMIR FLEXPEN 100 UNIT/ML 3ML medication. The award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This contract award is a delivery order (SPE2DB21FW74R) from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Levemir 100 Unit/ML Vial 10ML. The award is valued at $12,633.18 and has an ultimate completion date of August 19, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,794.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of LEVEMIR 100 UNIT/ML VIAL 10ML, a prescription pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
- This federal contract award is for the delivery of LEVEMIR 100 UNIT/ML VIAL 10ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,588.74 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 16, 2023. The contract has an ultimate completion date of March 17, 2023 and is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $1,870.61 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LEVEMIR 100 UNIT/ML VIAL 10ML pharmaceutical products. This delivery order is part of an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This federal contract award, valued at $1,542.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LEVEMIR 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is December 19, 2024. The contract award is not designated with a set-aside, indicating open...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $1,032.60 fixed-price delivery order is for the supply of LEVEMIR 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of June 7, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN6X2Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,095.15 firm fixed-price delivery order is for the supply of LEVEMIR 100 UNIT/ML VIAL 10ML, a specialty medication. The contract has an ultimate completion date of May 20, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract was awarded through full and open competition with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/19/22 |